STING1 and cervical carcinoma: STING, a key innate immune signaling factor, plays a crucial role in the antitumor immune response across various cancers.[28] By comparing STING protein levels in cervical cancer tissues from immunotherapy‐sensitive and immunotherapy‐resistant patients, our study observed significantly higher STING protein levels in immunotherapy‐sensitive patients, suggesting a potential role for altered STING protein levels in clinical treatment response and prognostic evaluation in cervical cancer (Figure1A; and Table S1, Supporting Information).